Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 28th of September 2026

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of September 28th, we are planning to work on 14 projects, including:

Reimbursement

1. Delivering reimbursement analysis for molecular diagnostic technologies in 12 European countries
2. Delivering analysis of coverage and reimbursement framework for point-of-care tests in England, Germany, Italy, the Netherlands, and Spain
3. Delivering reimbursement analysis for minimally invasive treatment in the ophthalmology area in the Netherlands
4. Working on reimbursement landscape and market size analysis for protective technology in the radiotherapy area in Belgium, Denmark, Finland, Italy, the Netherlands, Norway, Spain, and Sweden

HEOR

1. Delivering validation of a health economic model in the cardiology area
2. Delivering an adaptation of a health economic model for a cardiovascular technology in the Kingdom of Saudi Arabia healthcare setting
3. Delivering an adaptation of a health economic model for an imaging diagnostic system in the UK
4. Developing a cost-consequence and budget impact model for minimally invasive treatment for atrial fibrillation
5. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
6. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
7. Working on the development of a value dossier for a personalized blood test in the oncology area
8. Working on the development of a value dossier for technology in the cardiovascular area
9. Working on the development of a stakeholder engagement and objection-handling framework in the HEOR field
10. Working on an evidence gap analysis to inform evidence-generation and market-shaping opportunities in the ophthalmology area

Let us know if you need any market access or HEOR support for your medical technology in Europe.